Citigroup’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.78M | Sell |
21,900
-500
| -2% | -$233K | ﹤0.01% | 1487 |
|
|
2025
Q4 | $10.2M | Sell |
22,400
-3,900
| -15% | -$1.68M | ﹤0.01% | 1521 |
|
|
2025
Q3 | $10.3M | Hold |
26,300
| – | – | ﹤0.01% | 1471 |
|
|
2025
Q2 | $11.7M | Buy |
26,300
+19,900
| +311% | +$9.17M | 0.01% | 1280 |
|
|
2025
Q1 | $3.1M | Sell |
6,400
-48,400
| -88% | -$22.6M | ﹤0.01% | 2332 |
|
|
2024
Q4 | $22.1M | Buy |
54,800
+11,300
| +26% | +$5.24M | 0.01% | 905 |
|
|
2024
Q3 | $20.2M | Buy |
43,500
+25,100
| +136% | +$12.1M | 0.01% | 938 |
|
|
2024
Q2 | $8.62M | Hold |
18,400
| – | – | 0.01% | 1329 |
|
|
2024
Q1 | $7.69M | Sell |
18,400
-63,000
| -77% | -$26.6M | 0.01% | 1425 |
|
|
2023
Q4 | $33.1M | Buy |
81,400
+37,900
| +87% | +$14M | 0.02% | 622 |
|
|
2023
Q3 | $15.1M | Buy |
43,500
+31,500
| +263% | +$11M | 0.01% | 910 |
|
|
2023
Q2 | $4.22M | Buy |
+12,000
| New | +$4.04M | ﹤0.01% | 1608 |
|
|
2023
Q1 | – | Sell |
-4,900
| Closed | -$1.42M | – | 5894 |
|
|
2022
Q4 | $1.42M | Sell |
4,900
-25,300
| -84% | -$7.71M | ﹤0.01% | 2306 |
|
|
2022
Q3 | $8.74M | Sell |
30,200
-36,800
| -55% | -$10.6M | 0.01% | 1208 |
|
|
2022
Q2 | $18.9M | Buy |
67,000
+20,000
| +43% | +$5.35M | 0.01% | 823 |
|
|
2022
Q1 | $12.3M | Sell |
47,000
-55,000
| -54% | -$13.1M | 0.01% | 1193 |
|
|
2021
Q4 | $22.4M | Buy |
102,000
+33,000
| +48% | +$6.42M | 0.01% | 945 |
|
|
2021
Q3 | $12.5M | Sell |
69,000
-95,000
| -58% | -$18.5M | 0.01% | 1278 |
|
|
2021
Q2 | $33.1M | Buy |
164,000
+125,000
| +321% | +$26.1M | 0.02% | 725 |
|
|
2021
Q1 | $8.38M | Sell |
39,000
-46,500
| -54% | -$10.2M | 0.01% | 1470 |
|
|
2020
Q4 | $20.2M | Buy |
85,500
+32,500
| +61% | +$7.46M | 0.01% | 1024 |
|
|
2020
Q3 | $14.4M | Buy |
53,000
+4,200
| +9% | +$1.16M | 0.01% | 1113 |
|
|
2020
Q2 | $14.2M | Buy |
48,800
+700
| +1% | +$190K | 0.01% | 1070 |
|
|
2020
Q1 | $11.4M | Sell |
48,100
-31,300
| -39% | -$7.18M | 0.01% | 1069 |
|
|
2019
Q4 | $17.4M | Sell |
79,400
-21,700
| -21% | -$4.39M | 0.01% | 1065 |
|
|
2019
Q3 | $17.1M | Buy |
101,100
+18,100
| +22% | +$3.2M | 0.01% | 1015 |
|
|
2019
Q2 | $15.2M | Sell |
83,000
-26,300
| -24% | -$4.6M | 0.01% | 1098 |
|
|
2019
Q1 | $20.1M | Sell |
109,300
-1,400
| -1% | -$259K | 0.02% | 825 |
|
|
2018
Q4 | $18.3M | Sell |
110,700
-17,100
| -13% | -$2.96M | 0.02% | 882 |
|
|
2018
Q3 | $24.6M | Buy |
127,800
+26,400
| +26% | +$4.7M | 0.02% | 716 |
|
|
2018
Q2 | $17.2M | Buy |
101,400
+9,800
| +11% | +$1.52M | 0.02% | 897 |
|
|
2018
Q1 | $14.9M | Buy |
91,600
+23,200
| +34% | +$3.79M | 0.01% | 977 |
|
|
2017
Q4 | $10.3M | Sell |
68,400
-37,800
| -36% | -$5.6M | 0.01% | 1278 |
|
|
2017
Q3 | $16.1M | Buy |
106,200
+48,500
| +84% | +$7.3M | 0.01% | 907 |
|
|
2017
Q2 | $7.44M | Buy |
57,700
+28,600
| +98% | +$3.44M | 0.01% | 1384 |
|
|
2017
Q1 | $3.18M | Sell |
29,100
-21,600
| -43% | -$1.9M | ﹤0.01% | 2035 |
|
|
2016
Q4 | $3.73M | Sell |
50,700
-11,100
| -18% | -$903K | ﹤0.01% | 2176 |
|
|
2016
Q3 | $5.39M | Buy |
61,800
+15,500
| +33% | +$1.46M | 0.01% | 1600 |
|
|
2016
Q2 | $3.98M | Sell |
46,300
-4,200
| -8% | -$363K | ﹤0.01% | 1777 |
|
|
2016
Q1 | $4.01M | Sell |
50,500
-3,500
| -6% | -$317K | ﹤0.01% | 1752 |
|
|
2015
Q4 | $6.79M | Buy |
54,000
+24,600
| +84% | +$2.97M | 0.01% | 1434 |
|
|
2015
Q3 | $3.06M | Buy |
29,400
+13,300
| +83% | +$1.71M | ﹤0.01% | 2092 |
|
|
2015
Q2 | $1.99M | Buy |
16,100
+900
| +6% | +$113K | ﹤0.01% | 2519 |
|
|
2015
Q1 | $1.79M | Sell |
15,200
-63,400
| -81% | -$7.6M | ﹤0.01% | 2574 |
|
|
2014
Q4 | $9.34M | Sell |
78,600
-43,900
| -36% | -$4.94M | 0.01% | 1328 |
|
|
2014
Q3 | $13.8M | Sell |
122,500
-194,000
| -61% | -$18.5M | 0.01% | 1053 |
|
|
2014
Q2 | $30M | Buy |
316,500
+147,700
| +88% | +$10.4M | 0.03% | 561 |
|
|
2014
Q1 | $11.9M | Sell |
168,800
-18,800
| -10% | -$1.49M | 0.01% | 1030 |
|
|
2013
Q4 | $13.9M | Buy |
187,600
+53,800
| +40% | +$3.75M | 0.01% | 986 |
|
|
2013
Q3 | $10.1M | Sell |
133,800
-14,800
| -10% | -$1.18M | 0.01% | 1148 |
|
|
2013
Q2 | $11.9M | Buy |
+148,600
| New | +$10.9M | 0.01% | 968 |
|
Other funds holding VRTX
VCM
VPM
Citigroup's VRTX Position: Q1 2026 in Review
Citigroup increased its Vertex Pharmaceuticals (VRTX) stake by 26% in Q1 2026, buying an estimated $66.6M and bringing the position to 682,807 shares worth $305M. The position accounts for 0.13% of the portfolio, ranked #153.
Citigroup first reported a position in VRTX in Q2 2013 and has held it in 52 quarters since. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Citigroup held 682,807 shares of Vertex Pharmaceuticals worth $305M as of Q1 2026.
- Citigroup bought 142,877 Vertex Pharmaceuticals shares in Q1 2026, an estimated $66.6M.
- Vertex Pharmaceuticals made up 0.13% of Citigroup's portfolio in Q1 2026, its #153 holding.
- Citigroup first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.